Nea Management Company, LLC

Investment Portfolio & 13F Holdings Analysis

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-14
Total Holdings
38
Total Value
1298444752
Accession Number
0000897069-25-000979
Form Type
13F-HR
Manager Name
Nea-Management-Company
Data Enrichment
97% identified
37 identified1 unidentified

Holdings

38 positions
Manager:
Search and click to pin securities to the top
Page 1 of 2
Arcellx, Inc.
Shares:3.7M
Value:$245.7M
Verona Pharma plc
Shares:2.7M
Value:$170.7M
RHYTHM PHARMACEUTICALS, INC.
Shares:2.9M
Value:$154.1M
Tempus AI, Inc.
Shares:2.6M
Value:$126.2M
Coursera, Inc.
Shares:12.9M
Value:$85.7M
Trevi Therapeutics, Inc.
Shares:11.4M
Value:$71.5M
Savara Inc
Shares:24.5M
Value:$67.8M
CRISPR Therapeutics AG
Shares:1.6M
Value:$54.0M
Monte Rosa Therapeutics, Inc.
Shares:7.7M
Value:$35.7M
Aurinia Pharmaceuticals Inc.
Shares:4.0M
Value:$31.9M
MBX Biosciences, Inc.
Shares:3.6M
Value:$26.7M
CVRx, Inc.
Shares:2.0M
Value:$24.8M
Zenas BioPharma, Inc.
Shares:2.6M
Value:$20.7M
Gossamer Bio, Inc.
Shares:18.1M
Value:$19.9M
Korro Bio, Inc.
Shares:1.1M
Value:$19.0M
NeueHealth, Inc.
Shares:2.7M
Value:$18.4M
CHAMPIONS ONCOLOGY, INC.
Shares:1.7M
Value:$14.9M
Senti Biosciences, Inc.
Shares:3.8M
Value:$12.7M
Celcuity Inc.
Shares:1.3M
Value:$12.6M
Phathom Pharmaceuticals, Inc.
Shares:2.0M
Value:$12.3M